A newly published systematic review and meta-analysis by Yang et al. delves deeply into this controversy, offering a comprehensive evaluation of immune-inflammatory biomarkers in adults with obesity compared to non-obese counterparts. The authors meticulously aggregated data from multiple studies, harnessing the power of meta-analytic techniques to clarify whether these hematological indices can serve as reliable surrogates for obesity-associated inflammation. This work stands as a critical juncture in obesity research, as it systematically examines not only the associations but also the underlying sources of heterogeneity contributing to inconsistent findings in previous literature.

Obesity is characterized by a persistent state of low-grade inflammation, distinguished from the overt inflammation seen in infections by its subtle, chronic nature. This inflammatory phenotype involves a complex interplay of immune cells, adipocytes, and adipose tissue-resident macrophages, contributing to the release of pro-inflammatory cytokines such as TNF-alpha, IL-6, and CRP. These systemic signals, although modest in magnitude, have measurable effects on metabolic pathways, immunity, and cardiovascular risk profiles, underscoring the need for dependable clinical markers to monitor inflammation in obese individuals.

NLR and PLR have emerged as cost-effective, accessible indices derived from routine complete blood counts (CBC), posited as indicators of systemic inflammation. The neutrophil-to-lymphocyte ratio encapsulates the balance between innate immune activation and adaptive immune regulation, with neutrophils representing acute inflammatory response and lymphocytes reflecting immune competence. Similarly, PLR considers platelets, which not only participate in hemostasis but also modulate inflammatory processes, against lymphocyte counts. Together, these ratios are gaining traction for their simplicity and prognostic value in various inflammatory and cardiovascular disorders.

Beyond these traditional markers, the systemic immune-inflammation index (SII) integrates three parameters—neutrophils, lymphocytes, and platelets—into a composite score designed to provide a more holistic view of systemic inflammation and immune response. The systemic inflammation response index (SIRI) takes a slightly different approach, incorporating monocyte counts alongside neutrophils and lymphocytes. These indices aim to capture the multifaceted nature of inflammation more accurately than single-cell ratios can, potentially offering enhanced sensitivity and specificity.

Yang et al.’s meta-analysis evaluates the alterations in these markers in adults with established obesity, analyzing data extracted from a wide array of clinical studies. Their findings reveal that individuals with obesity tend to exhibit elevated levels of NLR, PLR, SII, and SIRI compared to lean controls, suggesting that these indices could indeed reflect the inflammatory status characteristic of adiposity. However, the magnitude and consistency of these associations vary significantly across studies, highlighting underlying heterogeneity.

Several factors contribute to this variability. Differences in study design, population demographics, comorbidities, and methodological approaches—such as the timing and conditions of blood sample collection—may affect biomarker levels. Moreover, obesity itself is heterogeneous, with variations in fat distribution, metabolic health, and inflammation degree influencing immune-inflammatory profiles. These complexities underscore the need for standardized protocols and consideration of confounding factors when applying these indices clinically or in research.

Importantly, the meta-analysis identifies that age, sex, and geographic location serve as potential moderators influencing the association between immune-inflammatory markers and obesity. For instance, older individuals may exhibit higher baseline inflammation due to immunosenescence, potentially inflating NLR and related indices independent of obesity status. Similarly, sex differences in immune function—driven by hormonal influences—modulate inflammatory responses, necessitating tailored interpretation of biomarker data.

Clinical implications of these findings are both promising and cautionary. On one hand, using routine blood parameters to monitor systemic inflammation in obesity could facilitate early detection of metabolic complications, guide individualized therapeutic interventions, and track responses to weight loss or anti-inflammatory treatments. Such biomarkers could be integrated into risk stratification models, improving patient management and outcomes. On the other hand, without standardized thresholds and comprehensive understanding of confounding variables, reliance on these indices could lead to misinterpretation or overestimation of inflammatory burden.

The study also highlights potential avenues for future research. Longitudinal studies are needed to elucidate how changes in NLR, PLR, SII, and SIRI correspond with weight fluctuations, metabolic improvements, or the development of obesity-related complications. Exploration of these indices in diverse ethnic populations and across different obesity phenotypes could unravel patterns masked in aggregated analyses. Additionally, combining these systemic markers with tissue-specific inflammatory assessments or advanced molecular profiling might enhance the precision of obesity inflammation phenotyping.

Technological advancements in hematological analysis and biomarker discovery may also expand the repertoire of accessible inflammation indices. Integration of artificial intelligence and machine learning could refine the predictive power of combined hematological parameters beyond conventional ratios, potentially uncovering novel patterns linked to inflammatory trajectories in obesity. Such interdisciplinary approaches promise to revolutionize how we monitor and intervene in obesity-related inflammation.

In conclusion, the meta-analytic work of Yang and colleagues marks a pivotal step in validating peripheral blood-based immune-inflammatory markers as reflections of obesity-associated inflammation. While these indices offer valuable windows into the systemic inflammatory state, their clinical application demands nuanced understanding of biological and methodological heterogeneity. As obesity continues to impose a global health burden, harnessing such accessible biomarkers effectively could transform inflammation monitoring and pave the way for personalized therapeutic strategies in metabolic health.

The ongoing challenge lies in bridging the gap between research findings and pragmatic clinical tools. Translating these insights into standardized diagnostic or prognostic criteria necessitates collaborative efforts linking laboratory science, clinical medicine, and population health. As the field advances, the integration of immune-inflammatory indices with broader metabolic and cardiovascular risk assessments holds the potential to enhance precision medicine approaches for individuals grappling with obesity and its myriad complications.

Ultimately, the promise of routine hematological indices as beacons of obesity-associated inflammation underscores the evolving understanding of obesity as an immune-mediated condition. This paradigm shift opens new frontiers in both the basic science and clinical management of metabolic diseases, fostering hope for innovative interventions that target the inflammatory underpinnings of obesity to improve health outcomes worldwide.

Subject of Research: Association between immune-inflammatory biomarkers and obesity in adults

Article Title: Association between immune-inflammatory biomarkers (NLR, PLR, SII, SIRI) and obesity in adults: a systematic review and meta-analysis

Article References:
Yang, Y., Wang, J., Cai, J. et al. Association between immune-inflammatory biomarkers (NLR, PLR, SII, SIRI) and obesity in adults: a systematic review and meta-analysis. Int J Obes (2026). https://doi.org/10.1038/s41366-026-02108-0

Image Credits: AI Generated

DOI: 13 June 2026

The hs-CRP (high-sensitivity C-reactive protein) is an inflammatory marker that has been extensively studied in various health conditions, particularly cardiovascular diseases. Its elevation is often indicative of systemic inflammation and is associated with a variety of metabolic disorders. In contrast, HDL-C (high-density lipoprotein cholesterol) is frequently dubbed as “good cholesterol” due to its role in transporting cholesterol away from arteries and back to the liver, where it can be processed and excreted. The interplay between these two biomarkers could offer a distinctive perspective not only on inflammation but also on metabolic health.

Through their extensive cross-sectional study, the researchers meticulously analyzed data derived from NHANES, a richly populated dataset that provides invaluable insights into the health and nutrition of the U.S. population. The team examined over thousands of participants, aiming to uncover the relationship between the hs-CRP/HDL-C ratio and the pathways leading to prediabetes and diabetes. This type of analysis represents a critical step forward in understanding how inflammatory markers interact with lipid profiles in relation to insulin resistance and glucose metabolism.

Particularly noteworthy is the meticulous methodology employed in this study. The researchers standardized their parameters, ensuring robust data collection and analysis. This attention to detail not only enhances the validity of their findings but also paves the way for future studies to replicate or expand upon their results. By focusing on the hs-CRP/HDL-C ratio, they have aimed to highlight potential interventions that may mitigate the risk factors leading to metabolic disorders.

The examination of participants revealed a stark correlation: higher hs-CRP levels corresponded with lower HDL-C levels, which, in turn, appeared to elevate the risk of prediabetes and diabetes significantly. These findings resonate with a growing body of literature advocating for the importance of monitoring inflammatory markers and lipid levels in the general population, particularly in at-risk groups. As obesity and sedentary lifestyles continue to escalate alongside rising diabetes rates globally, this study offers a crucial lens through which health professionals can scrutinize patient profiles.

Inflammation is hypothesized to play a foundational role in insulin resistance—a hallmark of prediabetes and diabetes. The body’s inflammatory response can interfere with insulin signaling pathways, leading to an impaired capacity to regulate blood sugar levels. By illustrating how the hs-CRP/HDL-C ratio serves as a potential predictor of diabetes, this study opens new avenues for preventive measures targeting inflammation and lipid management.

Additionally, the implications of such research extend beyond observational associations. Health practitioners could leverage these findings to develop targeted screening protocols for individuals at heightened risk. For instance, incorporating hs-CRP and HDL-C measurements in routine check-ups may enable earlier identification of at-risk patients, optimizing intervention strategies before the progression to full-blown diabetes occurs.

Furthermore, the research community may see a shift toward holistic approaches that include lifestyle modifications aimed at reducing inflammation and improving lipid profiles simultaneously. Simple yet effective strategies, such as dietary changes and increased physical activity, could play a transformative role in managing and preventing prediabetes and diabetes. This holistic view aligns seamlessly with current public health initiatives advocating for lifestyle interventions as a first line of defense against chronic diseases.

These findings also suggest potential future research directions, including longitudinal studies that track the hs-CRP/HDL-C ratio over time to determine causal relationships. Investigating whether targeted interventions that lower hs-CRP or raise HDL-C can effectively reduce the incidence of prediabetes and diabetes represents another pathway ripe for exploration. As the scientific community delves deeper into the mechanisms of diabetes, understanding the role of these biomarkers will become increasingly paramount.

The broader societal implications of this research cannot be overlooked. With diabetes prevalence soaring, effective strategies are urgently needed to tackle this public health crisis. Studies like this, illuminating the connection between inflammation and metabolic disease, can guide policy-making, ensure the availability of resources for diabetes prevention programs, and ultimately lead to healthier populations.

In summary, the correlation between the hs-CRP/HDL-C ratio and the risk of prediabetes and diabetes presents an exciting frontier in diabetes research. It emphasizes the intricate relationships between inflammation, lipid metabolism, and metabolic health. As researchers continue to unravel these complex interactions and their implications for patient care, the hope is that novel insights will lead to effective prevention strategies, ultimately reducing the burden of diabetes in society.

The publication of this research in BMC Endocrine Disorders signifies a pivotal contribution to the ever-evolving landscape of diabetes research. As clinical and public health communities increasingly recognize the significance of inflammation in metabolic diseases, the hitherto overlooked hs-CRP/HDL-C ratio may soon take center stage as a pivotal marker in preventive strategies against diabetes.

In conclusion, as we move forward, the research community must remain vigilant and proactive in investigating how novel findings like these can enhance our understanding of diabetes prevention and management. Through concerted efforts, it is possible to turn the tide on rising diabetes rates and foster healthier futures for populations worldwide.

Subject of Research: Association between hs-CRP/HDL-C ratio and risk of prediabetes or diabetes.

Article Title: Association between hs-CRP/HDL-C ratio and risk of prediabetes or diabetes: a cross-sectional study based on NHANES 2015–2023.

Article References:

Sun, H., Yang, J., Ma, L. et al. Association between hs-CRP/HDL-C ratio and risk of prediabetes or diabetes: a cross-sectional study based on NHANES 2015–2023.
BMC Endocr Disord 25, 183 (2025). https://doi.org/10.1186/s12902-025-02004-0

Image Credits: AI Generated

DOI: 10.1186/s12902-025-02004-0

Keywords: hs-CRP, HDL-C, diabetes, inflammation, metabolism, prediabetes, NHANES, biomarkers, public health, preventive strategies.